Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

Source:http://linkedlifedata.com/resource/pubmed/id/21148750

Cancer Res. 2011 Feb 1 71 3 675-85

Download in:

View as

Triples

General Info

PMID
21148750